CARLYLE <CG.O> TARGETING MARKET VALUE OF 300 BLN YEN ($2.1 BLN) FOR RIGAKU, SAY SOURCES
By Miho Uranaka, Kane Wu and Sam Nussey
TOKYO, Sept 19 (Reuters) -Japan's Rigaku, a maker of X-ray testing tools backed by buyout firm Carlyle Group CG.O, is preparing for a domestic initial public offering (IPO) in October, two sources familiar with the matter said.
Carlyle is targeting a market value for Rigaku of around 300 billion yen ($2.09 billion) in the IPO, one of the sources and a third source said.
A listing is not certain and, depending on market conditions, may be cancelled or rescheduled, one of the sources said.
Japan's stock market suffered a historic rout in early August sparked by a surprise rate hike and fears of a U.S. recession, before regaining ground.
Nomura, Morgan Stanley and Bank of America are joint global coordinators, two of the sources said.
Rigaku, Carlyle, Nomura, Morgan Stanley and Bank of America declined to comment. The sources declined to be identified as the information is not public.
Carlyle will sell shares in the IPO, the sources said.
Subway operator Tokyo Metro and chipmaker Kioxia are both targeting listings in October, Reuters has reported.
Carlyle announced in January 2021 it was acquiring a roughly 80% stake in Rigaku through its fourth Japan buyout fund, with the company's then-CEO Hikaru Shimura holding a roughly 20% stake.
Rigaku said at the time it is targeting growing demand for X-ray equipment due to the miniaturisation of semiconductors and electronic components, and aims to list in the coming years.
The growing complexity of chip manufacturing processes is driving the need for testing with Rigaku's tools, which are offered for research and development, and production.
Rigaku also sells its equipment to industries such as materials science and pharmaceuticals.
Founded in 1951, Rigaku booked revenue of 80 billion yen in 2023, up around a quarter from a year earlier, and makes 70% of its sales overseas.
Rigaku's peers include Spectris-owned SXS.L Malvern Panalytical, located in Britain, and U.S.-based Bruker BRKR.O.
Jun Kawakami, formerly an executive at General Electric and Arteria Networks, became CEO last year, with Shimura serving as chairman.
Buyout firms are making deals in Japan as companies shed non-core assets, go private, or management grapples with a lack of successors.
Carlyle's other investments in Japan include KFC Japan, Iwasaki Electric and Orion Breweries.
The firm said in May it has raised 430 billion yen in its largest ever investment vehicle for Japan.
($1 = 143.4800 yen)
Reporting by Miho Uranaka and Sam Nussey in Tokyo and Kane Wu in Hong Kong; Editing by Muralikumar Anantharaman
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
